Quarterly report · Q2
2689.TEDINET S100SVKV
Period2023-07-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥57.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥110.5bn | 2022-07-01 → 2023-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥53.7bn | 2022-07-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥747m | 2023-07-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥854m | 2022-07-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥746m | 2023-07-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.2bn | 2022-07-01 → 2023-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥859m | 2022-07-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥745m | 2023-07-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥857m | 2022-07-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥486m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2022-07-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥548m | 2022-07-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥486m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥548m | 2022-07-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥43.4bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥40.9bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥40.6bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥33.3bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥30.6bn | at 2023-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥10.2bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥10.3bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥9.3bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.9bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.4bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.9bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2022-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥146m | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥660m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.9bn | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥347m | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥306m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥143m | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.0bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥176m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.5bn | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥81.01 | 2023-07-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.16 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥234.9 | 2022-07-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥91.09 | 2022-07-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥49.24 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 23.4% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.3% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.9% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-12-31 | −¥725m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-12-31 | −¥725m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-12-31 | −¥76m |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥1.3bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥1.3bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥1m |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥102m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥54.3bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥53.6bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥656m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥669m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥2.6bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥2.5bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥68m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥52m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2023-12-31 | ¥58.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2023-12-31 | ¥57.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥725m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2023-12-31 | ¥823m |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-12-31 | −¥789m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-12-31 | −¥789m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-12-31 | −¥71m |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥104,000 |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥92m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥50.7bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥50.0bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥726m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥735m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥2.6bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥2.5bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥64m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥98m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2022-12-31 | ¥54.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2022-12-31 | ¥53.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥789m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2022-12-31 | ¥925m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 493
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -789354000 | JPY |
| Net sales | Prior1YTDDuration | 53718093000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02928-000MedicalEquipmentReportableSegmentsMember | 735259000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02928-000SPDReportableSegmentsMember | 97731000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02928-000CareNursingGoodsReportableSegmentsMember | 91695000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 924686000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -70600000 | JPY |
| Operating income | Prior1YTDDuration | 854086000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02928-000MedicalEquipmentReportableSegmentsMember | 53628050000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02928-000SPDReportableSegmentsMember | 2522060000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02928-000CareNursingGoodsReportableSegmentsMember | 1316194000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 57466305000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 57466305000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02928-000MedicalEquipmentReportableSegmentsMember | 655999000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02928-000SPDReportableSegmentsMember | 67974000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02928-000CareNursingGoodsReportableSegmentsMember | 1192000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 725165000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -725165000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02928-000MedicalEquipmentReportableSegmentsMember | 54284050000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02928-000SPDReportableSegmentsMember | 2590034000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02928-000CareNursingGoodsReportableSegmentsMember | 1317386000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 58191471000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -725165000 | JPY |
| Net sales | CurrentYTDDuration | 57466305000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02928-000MedicalEquipmentReportableSegmentsMember | 668811000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02928-000SPDReportableSegmentsMember | 52255000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02928-000CareNursingGoodsReportableSegmentsMember | 101872000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 822939000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -76040000 | JPY |
| Operating income | CurrentYTDDuration | 746899000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)中国財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-02-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第75期第２四半期(自 2023年10月１日 至 2023年12月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)オルバヘルスケアホールディングス株式会社 | |
| Company name in english cover page | FilingDateInstant | ＯＬＢＡ ＨＥＡＬＴＨＣＡＲＥ ＨＯＬＤＩＮＧＳ，Ｉｎｃ． | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 前島 洋平 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)岡山市北区下石井一丁目１番３号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | ０８６－２３６－１１１５ | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)常務取締役管理本部長 村田 宣治 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)岡山市北区下石井一丁目１番３号 日本生命岡山第二ビル | |
| Telephone number nearest place of contact cover page | FilingDateInstant | ０８６－２３６－１１１５ | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)常務取締役管理本部長 村田 宣治 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E02928 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 26890 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |